US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 4, 2020 (6 years ago)

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 50 count (NDC…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

What was recalled

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 50 count (NDC 50268-531-15); b) 90 count (NDC 42291-610-90); c) 180 count (NDC 42291-610-18); d) 360 count (NDC 42291-610-36); e) 1000 count (NDC 42291-610-10) bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Recalling firm
AVKARE Inc.
NDC code
50268-531-15
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1305-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all